mentrual irregularity, acne and facial hiar disease study

Effect of majoon idrare haiz in PCOS-A pilot study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/10/015900

Enrollment

Registered

2018-10-05

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: poly herbal formulation: in semi solid jelly form Control Intervention1: nil: nil

Eligibility

Inclusion criteria

Inclusion criteria: amenorrhoea and/ or oligomenorrhoea clinical evidence of hyperandrogenism PCO on USG

Exclusion criteria

Exclusion criteria: 1. Patients with Insulin sensitizing treatment within 3 months16 2. Patients with Hormonal treatment 3. Patients with H/o DM, Hypertension 4. Pregnant and lactating women. 16

Design outcomes

Primary

Measure	Time frame
menstrual regulationTimepoint: 3 cycles	—

Secondary

Measure	Time frame
change in ovarian morphologyTimepoint: 3 cycles	—

Countries

India

Contacts

Public ContactKouser Fathima Firdose

national institute of unani medicine

kouser2fathima@gmail.com9743730208

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026